Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in kids and grown-ups . In Canada, its access is overseen by Health Canada. This https://tevalisdexamfetaminefors160137.ssnblog.com/41678728/this-medication-in-canada-a-detailed-guide